ロード中...
Rhabdomyolysis: a rare adverse effect of levetiracetam
A 62-year-old previously healthy male was admitted with new onset generalised tonic-clonic seizures. Treatment was initiated with the antiepileptic levetiracetam and he had no further episodes of seizures. Creatine kinase (CPK) level was 1812 IU/L 12-hour postadmission. Despite good hydration, his C...
保存先:
| 出版年: | BMJ Case Rep |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6720964/ https://ncbi.nlm.nih.gov/pubmed/31451475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-230851 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|